A Phase IV Study to Explore the Safety of ORal IrON Supplementation With Ferric Maltol in Treating Iron Deficiency in Patients With Heart Failure Carrying Left Ventricular Assist Devices (ORION-LVAD-1)
Latest Information Update: 03 Oct 2021
At a glance
- Drugs Ferric maltol (Primary)
- Indications Iron deficiency anaemia
- Focus Adverse reactions
- Acronyms ORION-LVAD-1
Most Recent Events
- 17 Jan 2020 Status changed from discontinued to completed.
- 20 Dec 2019 Status changed from recruiting to discontinued.
- 04 Mar 2019 Planned initiation date (estimated date for recruitment of the first subject) changed from 15 Feb 2019 to 1 Mar 2019.